EUVIMEDOpdag EUVIMED
Crossref

Utility of SOX17 Immunohistochemical Stain in Serous Fluid Cytology Cell Block Specimens

Neharika Shrestha, Xulang Zhang, Syed M Gilani iD

Diagnostic Cytopathology · 2025

DOI: 10.1002/dc.25468 ↗

At a glance

Journal article in Diagnostic Cytopathology, 2025. Written by Neharika Shrestha and 2 co-authors. Institution: Department of Pathology, Albany Medical Center, Albany, New York, USA. Major MEDLINE topics: SOXF Transcription Factors, Biomarkers, Tumor, Genital Neoplasms, Female. Cited 2 times so far (Crossref); 16 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The identification of metastatic tumors in serous fluid cytology specimens (SFCS) has always been a challenge. In this study, we explored SOX17 as an immunohistochemical (IHC) marker for the diagnosis of metastatic gynecologic tumors in body fluid specimens.

Methods

We selected 97 tumor cases, including 85 SFCS with adequate cell block material (from gynecologic primary, n = 30 and others, n = 55) and 12 histology specimens (thymic and thyroid tumors). SOX17 IHC was performed on all selected cases, and results were interpreted as positive or negative. Positive results were further characterized by intensity (nuclear staining) as weak (1+), moderate (2+), and strong (3+) and percentage of positive cells as focal (< 10%), patchy (10%–50%) and diffuse (> 50%).

Results

In SFCS of gynecologic primary tumors, SOX17 exhibited strong nuclear staining in 28 out of 30 tumors, with two cases showing moderate staining. All non‐gynecologic metastatic tumors in effusion cytology specimens were SOX17‐negative except for one case of renal cell carcinoma, which displayed a moderate patchy staining pattern. All histology cases consisting of thymic and thyroid tumors were negative for SOX17.

Conclusions

In this study, all tumors of gynecologic tract origin in effusion SFCS were SOX17 positive, while all other non‐gynecologic tumors were negative for SOX17 except for one case. This finding suggests that SOX17 IHC is an excellent addition to the IHC panel while working up tumors at metastatic sites, specifically when gynecologic primary tumors are in the differential diagnosis.

Subjects

MeSH terms (MEDLINE)

SOXF Transcription FactorsBiomarkers, TumorGenital Neoplasms, FemaleHumansFemaleImmunohistochemistryCytodiagnosisMiddle AgedAdultAgedAscitic Fluid

Author keywords

SOX17cell blockeffusion cytologygynecologic tract tumorsimmunohistochemical staining

Substances

SOXF Transcription FactorsBiomarkers, TumorSOX17 protein, human

Authors and institutions

  • Department of Pathology, Albany Medical Center, Albany, New York, USA.
  • Department of Pathology, Albany Medical Center/Albany Medical College, Albany, New York, USA.

ORCID profiles: Syed M Gilani

Cite

APA

Shrestha, N., Zhang, X., & Gilani, S. M. (2025). Utility of SOX17 Immunohistochemical Stain in Serous Fluid Cytology Cell Block Specimens. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25468

Vancouver

Shrestha N, Zhang X, Gilani SM. Utility of SOX17 Immunohistochemical Stain in Serous Fluid Cytology Cell Block Specimens. Diagnostic Cytopathology. 2025. doi:10.1002/dc.25468

BibTeX
@article{Shrestha2025,
  author = {Shrestha, Neharika and Zhang, Xulang and Gilani, Syed M},
  title = {Utility of SOX17 Immunohistochemical Stain in Serous Fluid Cytology Cell Block Specimens},
  journal = {Diagnostic Cytopathology},
  year = {2025},
  doi = {10.1002/dc.25468}
}
Start for free →